29 related articles for article (PubMed ID: 38605473)
1. Patient- and Clinician-Reported Outcomes for Tirbanibulin in Actinic Keratosis in Clinical Practice Across the United States (PROAK).
Schlesinger T; Kircik L; Lebwohl M; Patel VA; Berman B; Bhatia N; Rigel D; Armstrong A; Rosso JD; Narayanan S; Koscielny V
J Drugs Dermatol; 2024 May; 23(5):338-346. PubMed ID: 38709702
[TBL] [Abstract][Full Text] [Related]
2. Tirbanibulin ointment: A new effective and safe treatment of recalcitrant viral warts.
Mansilla-Polo M; Abril-Pérez C; Martín-Torregrosa D
Semergen; 2024 Jun; 50(8):102278. PubMed ID: 38924858
[No Abstract] [Full Text] [Related]
3. Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study.
Kirchberger MC; Gfesser M; Erdmann M; Schliep S; Berking C; Heppt MV
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510952
[TBL] [Abstract][Full Text] [Related]
4. Anti-aging Effects of Tirbanibulin 1% Ointment: A Real-Life Experience.
Li Pomi F; Peterle L; d'Aloja A; Di Tano A; Vaccaro M; Borgia F
Dermatol Ther (Heidelb); 2024 Jun; 14(6):1683-1696. PubMed ID: 38740726
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.
Pellacani G; Schlesinger T; Bhatia N; Berman B; Lebwohl M; Cohen JL; Patel GK; Kunstfeld R; Hadshiew I; Lear JT
J Eur Acad Dermatol Venereol; 2024 Jan; 38 Suppl 1():3-15. PubMed ID: 38116638
[TBL] [Abstract][Full Text] [Related]
6. Tirbanibulin 1% Ointment for Actinic Keratosis: Results from a Real-Life Study.
Li Pomi F; Vaccaro M; Pallio G; Rottura M; Irrera N; Borgia F
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399512
[No Abstract] [Full Text] [Related]
7. Reflectance confocal microscopy as noninvasive tool for monitoring tirbanibulin efficacy in actinic keratosis.
Venturi F; Veronesi G; Baraldi C; Dika E
Photodiagnosis Photodyn Ther; 2024 Jun; 48():104235. PubMed ID: 38851311
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients.
Nazzaro G; Carugno A; Bortoluzzi P; Buffon S; Astrua C; Zappia E; Trovato E; Caccavale S; Pellegrino V; Paolino G; Balestri R; Lacava R; Ciccarese G; Verdelli A; Barruscotti S; Valenti M; Toni G; Giacalone S; Zavattaro E; Gironi LC; Mercuri SR; Ribero S; Gisondi P; Sena P; Marzano AV
Int J Dermatol; 2024 Apr; ():. PubMed ID: 38605473
[TBL] [Abstract][Full Text] [Related]
9. 1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses.
Dao DD; Sahni VN; Sahni DR; Balogh EA; Grada A; Feldman SR
Ann Pharmacother; 2022 Apr; 56(4):494-500. PubMed ID: 34301153
[TBL] [Abstract][Full Text] [Related]
10. Tirbanibulin for the Treatment of Actinic Keratosis: A Review.
Miller AC; Adjei S; Temiz LA; Tyring SK
Skin Therapy Lett; 2022 Jul; 27(4):4-7. PubMed ID: 35857917
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]